A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?
OpenSymmetry
JULY 20, 2016
Sales in the pharmaceutical industry has been a rigid and consistent business. In some cases, incentive compensation (IC) methods have evolved to align with new regulations regarding specific sales metrics. The Patient Protection and Affordable Care Act (PPACA) required similar adjustments for medical device sales.
Let's personalize your content